ACHC Acadia Healthcare Company Inc.

ACADIA HEALTHCARE SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 14, 2018 to file lead plaintiff applications in a securities class action lawsuit against Acadia Healthcare Company, Inc. (NasdaqGS: ACHC), if they purchased the Company’s securities between February 23, 2017 and October 24, 2017, inclusive (the “Class Period”), including an August 22, 2017 public offering. This action is pending in the United States District Court for the Middle District of Tennessee.

What You May Do

If you purchased securities of Acadia and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-achc/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by May 14, 2018.

About the Lawsuit

Acadia and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On October 24, 2017, the Company disclosed negative financial results for 3Q 2017 including a reduction to its guidance for fiscal year 2017 and a significant cut to EBITDA relating to its U.K. facilities purportedly driven by “lower census and higher operating costs.”

On this news, the price of Acadia’s shares plummeted 26% to close at $32.68 per share.

About Kahn Swick & Foti, LLC

KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

EN
07/04/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Acadia Healthcare Company Inc.

Acadia Healthcare Company, Inc.: Update to credit analysis following n...

Our credit view of this issuer reflects its additional lawsuits and investigations, its moderate financial leverage and its risks related to rapid growth and expansion strategy.

Moody's Ratings affirms Acadia's Ba3 CFR, revises the outlook to negat...

Moody's Ratings (Moody's) affirmed the ratings of Acadia Healthcare Company, Inc. ("Acadia"), including its Corporate Family Rating (CFR) at Ba3 and Probability of Default Rating at Ba3-PD. We also affirmed Acadia's senior unsecured ratings at B1. There is no change to Acadia's Speculative Grade Liq...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Moody's Ratings downgrades Acadia Healthcare's Corporate Family Rating...

Moody's Ratings (Moody's) downgraded the ratings of Acadia Healthcare Company, Inc.'s ("Acadia"), including its Corporate Family Rating (CFR) to Ba3 from Ba2 and Probability of Default Rating to Ba3-PD from Ba2-PD. We also downgraded Acadia's senior unsecured ratings to B1 from Ba3 and changed Acadi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch